We welcome attendees to visit Booth 1311 for Comp. Tox info!
US FDA officials were among the first MultiCASE users when in 1996, MultiCASE introduced novel in-silico tools for federal regulatory applications. Since then, MultiCASE has continued to develop highly sophisticated software and QSAR models for assessing toxicological and pharmacological potential of chemical compounds used for ICH M7 regulatory submissions and research. All models follow OECD guidelines and can assist with satisfying the toxicological information requirements listed in REACH.